Physician profile
John Nelson
NPI 1174551923
$25,618.00
in general payments reported to CMS, 2019-2025
32 companies · $259 in 2025
The $259 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,064 · 2020: $4,658 · 2021: $5,476 · 2022: $4,677 · 2023: $4,638 · 2024: $1,846 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $4,843 · Food and Beverage: $1,899.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $4,843.26 |
| Food and Beverage | $1,899.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Epimed International, INC | $19,833.13 | 2019-2024 | Catheters and Needles, Extension Set |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $623.60 | 2019-2025 | Relistor |
| Medtronic, INC. | $623.49 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Spinal Simplicity, LLC | $589.46 | 2020 | |
| Abbott Laboratories | $379.73 | 2019-2024 | Eterna |
| Genesys Orthopedics Systems, L.L.C. | $349.05 | 2024 | Sacroiliac Joint Fusion System |
| Collegium Pharmaceutical, INC. | $330.58 | 2020-2025 | Belbuca, Xtampza |
| Stimwave Technologies Incorporated | $312.52 | 2020-2021 | |
| Forte Bio-Pharma LLC | $295.42 | 2022-2025 | Prolate, Nalocet, Tanlor |
| Relievant Medsystems, INC. | $276.78 | 2022 | |
| Nevro Corp. | $220.24 | 2019-2021 | |
| Pacira Therapeutics, INC. | $218.17 | 2019-2020 | |
| Stratus Medical, LLC | $198.34 | 2020-2023 | Nimbus |
| Virtus Pharmaceuticals LLC | $166.76 | 2021 | |
| Daiichi Sankyo INC. | $163.02 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $152.48 | 2019 | |
| Spr Therapeutics, INC | $131.93 | 2022 | |
| Stryker Corporation | $114.09 | 2021 | |
| Boston Scientific Corporation | $98.48 | 2020 | |
| Curonix LLC | $97.95 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Eisai INC. | $86.07 | 2020-2021 | |
| Sentynl Therapeutics, INC. | $61.37 | 2019 | |
| Scilex Pharmaceuticals INC. | $50.19 | 2019-2021 | |
| Biodelivery Sciences International, INC. | $44.18 | 2019-2020 | |
| Tersera Therapeutics LLC | $43.43 | 2019-2021 | |
| Amgen INC. | $39.97 | 2019-2022 | |
| Fisher & Paykel Healthcare INC | $28.83 | 2024 | Fisher & Paykel Healthcare |
| Nalu Medical, INC. | $21.89 | 2021 | |
| Calyxo, INC. | $21.53 | 2025 | Cvac Aspiration System |
| Grt US Holding, INC. | $15.91 | 2020 | |
| Allergan, INC. | $15.73 | 2019 | |
| Almatica Pharma LLC | $13.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.